Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1Advanced Breast Cancer 1

Interventions

Fulvestrant 5Anastrozole 5Letrozole 3exemestane 2Goserelin 2ribociclib 1palbociclib 1entinostat 1elacestrant 1apatinib 1abemaciclib 1Selective Estrogen Receptor Modulators 1RAD1901 1Paclitaxel 1Injections 1Gonadotropin-Releasing Hormone 1FCN-437c 1Everolimus 1Aromatase Inhibitors 1AZD9833 1AZD5305 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Advanced Breast Cancer × entinostat × Clear all
NCT03538171 2021-07-09

Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer

Taizhou EOC Pharma Co., Ltd.

Phase 3 Unknown
375 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡